![](/img/cover-not-exists.png)
A Phase 3 Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol after 1 Year of Therapy in Early Rheumatoid Arthritis Patients
Weinblatt, Michael E., Bingham, Clifton O., Burmester, Gerd-Rüdiger, Bykerk, Vivian P., Furst, Daniel E., Mariette, Xavier, van der Heijde, Désirée, van Vollenhoven, Ronald, Van Lunen, Brenda, EcoffetLanguage:
english
Journal:
Arthritis & Rheumatology
DOI:
10.1002/art.40196
Date:
June, 2017
File:
PDF, 1.07 MB
english, 2017